Pienta KJ - Search Results

1

Apoptosis of circulating tumor cells in prostate cancer patients.

Larson CJ, Moreno JG, Pienta KJ, Gross S, Repollet M, O'hara SM, Russell T, Terstappen LW. Larson CJ, et al. Among authors: pienta kj. Cytometry A. 2004 Nov;62(1):46-53. doi: 10.1002/cyto.a.20073. Cytometry A. 2004. PMID: 15472900 Free article.

2

Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease.

Chen BT, Loberg RD, Neeley CK, O'Hara SM, Gross S, Doyle G, Dunn RL, Kalikin LM, Pienta KJ. Chen BT, et al. Among authors: pienta kj. Urology. 2005 Mar;65(3):616-21. doi: 10.1016/j.urology.2004.10.053. Urology. 2005. PMID: 15780403

3

Global gene expression profiling of circulating tumor cells.

Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, Connelly MC, Terstappen LW, O'Hara SM. Smirnov DA, et al. Among authors: pienta kj. Cancer Res. 2005 Jun 15;65(12):4993-7. doi: 10.1158/0008-5472.CAN-04-4330. Cancer Res. 2005. PMID: 15958538

4

Signaling network of paclitaxel-induced apoptosis in the LNCaP prostate cancer cell line.

Panvichian R, Orth K, Pilat MJ, Day ML, Day KC, Yee C, Kamradt JM, Pienta KJ. Panvichian R, et al. Among authors: pienta kj. Urology. 1999 Oct;54(4):746-52. doi: 10.1016/s0090-4295(99)00224-1. Urology. 1999. PMID: 10510942

5

Tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-kappaB by an IkappaBalpha "super-repressor".

Muenchen HJ, Lin DL, Walsh MA, Keller ET, Pienta KJ. Muenchen HJ, et al. Among authors: pienta kj. Clin Cancer Res. 2000 May;6(5):1969-77. Clin Cancer Res. 2000. PMID: 10815922 Retracted.

6

Decreased galectin-3 expression in prostate cancer.

Pacis RA, Pilat MJ, Pienta KJ, Wojno K, Raz A, Hogan V, Cooper CR. Pacis RA, et al. Among authors: pienta kj. Prostate. 2000 Jul 1;44(2):118-23. doi: 10.1002/1097-0045(20000701)44:2<118::aid-pros4>3.0.co;2-u. Prostate. 2000. PMID: 10881021 Free article.

7

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.

de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D. de Bono JS, et al. Among authors: pienta kj. Clin Cancer Res. 2008 Oct 1;14(19):6302-9. doi: 10.1158/1078-0432.CCR-08-0872. Clin Cancer Res. 2008. PMID: 18829513 Free article.

8

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.

Scher HI, Jia X, de Bono JS, Fleisher M, Pienta KJ, Raghavan D, Heller G. Scher HI, et al. Among authors: pienta kj. Lancet Oncol. 2009 Mar;10(3):233-9. doi: 10.1016/S1470-2045(08)70340-1. Epub 2009 Feb 11. Lancet Oncol. 2009. PMID: 19213602 Free PMC article.

9

Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.

Zhang J, Lu Y, Pienta KJ. Zhang J, et al. Among authors: pienta kj. J Natl Cancer Inst. 2010 Apr 21;102(8):522-8. doi: 10.1093/jnci/djq044. Epub 2010 Mar 16. J Natl Cancer Inst. 2010. PMID: 20233997 Free PMC article. Review.

10

Circulating fibroblast-like cells in men with metastatic prostate cancer.

Jones ML, Siddiqui J, Pienta KJ, Getzenberg RH. Jones ML, et al. Among authors: pienta kj. Prostate. 2013 Jan;73(2):176-81. doi: 10.1002/pros.22553. Epub 2012 Jun 21. Prostate. 2013. PMID: 22718300 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

619 results

Search Page